Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Study sponsor: Scholar Rock, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-03-04Actual
Enrollment · participants102Actual
Source updated2026-01-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.